PDI Announces Appointment of Peter B. Tilles as TVG President
SADDLE RIVER, N.J.–Feb. 6, 2008–PDI, Inc. (NASDAQ:PDII), a provider of commercialization services to the biopharmaceutical industry, has named Peter B. Tilles as President of TVG Marketing Research and Consulting, effective immediately.
Mr. Tilles has more than 20 years experience in marketing, strategy, sales and business development. His expertise is in identifying new profitable revenue sources and driving business growth. Mr. Tilles is a co-founder and currently serves on the board of directors of MedAvante, Inc., a pharmaceutical R&D services company conducting centralized assessments for mood disorder clinical trials. He is also co-founder of RecordMyCalls.Com, an internet-based consumer protection/telecommunications company focused on providing virtual digital call recording capabilities to consumer’s and small/medium sized businesses. Prior to his entrepreneurial career, Mr. Tilles spent several years with Citigroup and UBS where he led or co-led the development of two online banking and brokerage businesses as well as multiple strategic planning initiatives. Most recently, Mr. Tilles was a consultant with The Bancorp Bank, focusing on a broad-range of strategic planning, product development and management areas. Mr. Tilles is also Board President of The Susan G. Komen Breast Cancer Foundation of Central & Southern New Jersey.
“I am extremely excited to bring Peter’s unique and valuable business perspective to TVG,” said Kevin Connolly, Executive Vice President and General Manager, PDI Diversified Marketing Services. “This is an exciting and challenging time for TVG and all companies serving the pharmaceutical industry. I look forward to working with Peter and anticipate a significant positive impact on TVG and PDI.”
About TVG
For almost 30 years, TVG Marketing Research & Consulting has focused on the successful marketing of healthcare products. It is an industry leader in primary, custom-designed marketing research, training and consulting services. The company offers a unique systematic approach to providing knowledge about markets and customers through evidence-based insights and an experience-based vision of what products can achieve. The TVG Marketing Seminar Series has provided healthcare-specific training in the planning and management of brand marketing and marketing research to over 6000 industry professionals. Our consulting services include a variety of strategic, positioning and competitive simulation workshops.
About PDI
PDI provides commercialization services for established and emerging biopharmaceutical companies. The Company is dedicated to maximizing the return on investment for its clients by providing strategic flexibility; sales, marketing and commercialization expertise.
PDI operates in two areas, Sales Services and Marketing Services. Our Sales Services include Performance Sales Teams(TM), which are dedicated teams for specific customers; Select Access(TM), our targeted sales solution that leverages an existing infrastructure; and PDI ON DEMAND, innovative sales services that provide rapid, customized sales force solutions tailored to meet local, regional and seasonal needs. Our Marketing Services include marketing research and consulting services through TVG in Dresher, PA, and medical communications services through Pharmakon in Schaumburg, IL. In addition, PDI is a high-quality provider of continuing medical education through Vital Issues in Medicine (VIM(R)), located in Dresher, PA. PDI’s experience extends across multiple therapeutic categories and includes office- and hospital-based initiatives.
PDI’s commitment is to deliver innovative solutions, unparalleled execution and superior results for its customers. Recognized as an industry pioneer, PDI remains committed to continuous innovation and to retaining the industry’s highest-quality employees. For more information, please visit the Company’s website at www.pdi-inc.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding future events and financial performance. These statements involve a number of risks and uncertainties and are based on numerous assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI’s control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, the termination of or material reduction in the size of any of our customer contracts, the loss by our or our customers’ intellectual property rights, our ability or inability to secure new business to offset the recent loss of customer contracts and the terms of any replacement business we secure, changes in our operating expenses, FDA, legal or accounting developments, competitive pressures, failure to meet performance benchmarks in significant contracts, changes in customer and market requirements and standards, the impact of any stock repurchase programs, the adequacy of the reserves PDI has taken, the financial viability of certain companies whose debt and equity securities we hold, the outcome of certain litigation, PDI’s ability to implement its current and future business plans, and the risk factors detailed from time to time in PDI’s periodic filings with the Securities and Exchange Commission, including without limitation, PDI’s Annual Report on Form 10-K for the year ended December 31, 2006, and PDI’s subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K. The forward-looking statements in this press release are based upon management’s reasonable belief as of the date hereof. PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
CONTACT: PDI, Inc.
Jeffrey E. Smith, Chief Financial Officer, 201-258-8451
jesmith@pdi-inc.com
www.pdi-inc.com
or
Investor Contacts:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
Bruce Voss, 310-691-7100
bvoss@lhai.com
SOURCE: PDI, Inc.
This item was posted on Wednesday, February 6th, 2008 at 10:39 am and is filed under What's New.